| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.26 | 5e-07 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.095 | 0.05 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.045 | 0.3 |